Sunday, May 3, 2026
wellness India Expo
Home Tags Zydus

Tag: Zydus

Zydus gets DCGI’s approval for phase III clinical trials of its...

According to the company, Pegylated Interferon alpha – 2b significantly increased viral reduction and reduced the need for supplemental oxygen in moderate COVID-19 patients........................

Zydus completes Phase II clinical trials of COVID-19 biological therapy, to...

Pegylated Interferon alpha – 2b significantly increased viral reduction and reduced the need for supplemental oxygen in moderate COVID-19 patients; the Company will now commence Phase III clinical trials..............

DBT supported & Zydus driven COVID 19 vaccine, ZyCoV-D begins phase...

Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the National Biopharma Mission, implemented by BIRAC moves into clinical trials The study will assess the safety, tolerability and immunogenicity of the vaccine.................

COVID-19: NIV Pune develops India’s first indigenous IgG ELISA test, Zydus...

In a major breakthrough, Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV) at Pune has developed and validated the indigenous IgG ELISA test for antibody detection for COVID-19. ICMR has also partnered with Zydus Cadila for mass-scale production of the ELISA test kits...................

FOGSI & Bayer Zydus Pharma launch VISION for endometriosis to improve...

Over 200 thought leaders from across India were involved in formulating the protocols of practice on endometriosis after a national meeting in Mumbai followed by regional meetings in major cities......................

Zydus Cadila & IMTECH to jointly identify new drugs to tackle...

The research partnership between Zydus Cadilla and Institute of Microbial Technology, will primarily aim to identify new drug candidates for treatment of drug-resistant infections...……….

Zydus Cadila begins phase-2 trial of drug to cure anaemia in...

Zyani1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), is being tested as a viable treatment for anaemia associated with chronic kidney disease (CKD)...........